Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892-1088, USA.
Future Oncol. 2013 Oct;9(10):1501-13. doi: 10.2217/fon.13.123.
White light endoscopy has proven to be a very powerful tool in oncology. There is still, however, a need for better endoscopic techniques to overcome the current limitations of white light optics. New technologies that allow higher sensitivity, improved microanatomy and molecular characterization have been available for in vitro microscopy and are now being translated into in vivo endoscopy. Endoscopic molecular imaging is still in its infancy but holds the promise for enhancing sensitivity for early lesions, thus allowing earlier diagnosis and enabling early image-guided endoscopic intervention. A key feature of endoscopic molecular imaging is its increased sensitivity and specificity, which will be illustrated in this article, as well as describing perspectives on its future use in oncologic surgery.
白光内窥镜已被证明是肿瘤学中非常强大的工具。然而,仍然需要更好的内窥镜技术来克服当前白光光学的局限性。新的技术可以提高灵敏度、改善微观结构和分子特征,这些技术已经可用于体外显微镜,现在正在转化为体内内窥镜。内镜分子成像仍处于起步阶段,但有望提高对早期病变的敏感性,从而更早地诊断,并能够进行早期图像引导的内镜干预。内镜分子成像的一个关键特征是其更高的灵敏度和特异性,本文将对此进行说明,并描述其在肿瘤外科中的未来应用前景。